Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Statistical Methods to Analyze Parametric Data: ANOVA01:12

Statistical Methods to Analyze Parametric Data: ANOVA

Analysis of Variance, or ANOVA, is a powerful statistical technique used to analyze parametric data, primarily in research and experimental studies. It's designed to compare the means of two or more groups, assisting researchers in identifying any significant differences between these group means. There are two main types of ANOVA based on the complexity of the analysis: one-way and two-way.
One-way ANOVA is applied when a single independent variable or factor is scrutinized. It compares the...
Methods of Medium Optimization01:28

Methods of Medium Optimization

Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thermal acclimation and nitrogen deprivation drive distinct transcriptomic reprogramming toward a shared lipid phenotype in the polar marine microalga Chlamydomonas malina RCC2488.

Journal of biotechnology·2026
Same author

Co-Culture of Mammalian Cells and Photosynthetic Microorganisms for Oxygen Supply in Engineered Tissues.

Cell proliferation·2026
Same author

Extraction mechanisms of proteins from Palmaria palmata.

Food chemistry·2026
Same author

Intensification of Palmaria palmata protein biorefinery using multifrequency ultrasonication and enzymes.

Ultrasonics sonochemistry·2026
Same author

Real-time holographic monitoring of insect cell morphology during baculovirus coinfection for adeno-associated virus vector production using machine learning-based classification models.

New biotechnology·2026
Same author

Impact of multiplicity of infection and baculovirus co-infection ratio on recombinant adeno-associated virus vector production in insect cells.

Frontiers in bioengineering and biotechnology·2025
Same journal

High-level De novo Biosynthesis of Plant-Derived Pinosylvin in Yarrowia lipolytica via Metabolic Engineering and Surfactant-Mediated Fermentation.

Journal of biotechnology·2026
Same journal

The effect of reduced graphene oxide in chitosan-based nanoparticles on the enzymatic properties of the immobilized enzyme.

Journal of biotechnology·2026
Same journal

High-level biosynthesis of gastrodin in engineered Escherichia coli.

Journal of biotechnology·2026
Same journal

From plasmid sequence to process design: A computational analysis of metabolism in the context of plasmid DNA manufacturing.

Journal of biotechnology·2026
Same journal

Development of an inducible cellobiohydrolase promoter and its application for enhancing the production of ganoderic acids in Ganoderma lingzhi.

Journal of biotechnology·2026
Same journal

Malic acid and allied exogenous chemicals induces desaturase gene expression and elevates PUFA production in marine microalgae Isochrysis sp.

Journal of biotechnology·2026
See all related articles

Related Experiment Video

Updated: May 9, 2026

Application of Unsupervised Multi-Omic Factor Analysis to Uncover Patterns of Variation and Molecular Processes Linked to Cardiovascular Disease
08:51

Application of Unsupervised Multi-Omic Factor Analysis to Uncover Patterns of Variation and Molecular Processes Linked to Cardiovascular Disease

Published on: September 20, 2024

Multivariate data analysis as a PAT tool for early bioprocess development data.

Sarah M Mercier1, Bas Diepenbroek, Marcella C F Dalm

  • 1Crucell Holland BV, Process Development Department, Archimedesweg 4-6, 2333 CN Leiden, The Netherlands. smercier@its.jnj.com

Journal of Biotechnology
|July 23, 2013
PubMed
Summary
This summary is machine-generated.

Multivariate data analysis (MVDA) effectively analyzes early biopharmaceutical development data, uncovering insights missed by traditional methods. This approach enhances process understanding and efficiency, reducing development costs.

Keywords:
ATFBioprocessingCPPCQACell cultivationDODoEEarly developmentFDAFood and Drug AdministrationMFCSMVDAMultivariate data analysisPATPCPCAPDTPIDPLSProcess Analytical TechnologyQbDQuality by designalternating tangential flowcritical process attributecritical process parameterdesign of experimentdissolved oxygenmulti-fermentation control systemmultivariate data analysispartial least squarepopulation doubling timeprincipal componentprincipal component analysisproportional-integral-derivativequality by design

More Related Videos

An Analytical Tool-box for Comprehensive Biochemical, Structural and Transcriptome Evaluation of Oral Biofilms Mediated by Mutans Streptococci
11:09

An Analytical Tool-box for Comprehensive Biochemical, Structural and Transcriptome Evaluation of Oral Biofilms Mediated by Mutans Streptococci

Published on: January 25, 2011

Related Experiment Videos

Last Updated: May 9, 2026

Application of Unsupervised Multi-Omic Factor Analysis to Uncover Patterns of Variation and Molecular Processes Linked to Cardiovascular Disease
08:51

Application of Unsupervised Multi-Omic Factor Analysis to Uncover Patterns of Variation and Molecular Processes Linked to Cardiovascular Disease

Published on: September 20, 2024

An Analytical Tool-box for Comprehensive Biochemical, Structural and Transcriptome Evaluation of Oral Biofilms Mediated by Mutans Streptococci
11:09

An Analytical Tool-box for Comprehensive Biochemical, Structural and Transcriptome Evaluation of Oral Biofilms Mediated by Mutans Streptococci

Published on: January 25, 2011

Area of Science:

  • Biotechnology
  • Chemical Engineering
  • Process Analytical Technology

Background:

  • Early development datasets in biopharmaceutical manufacturing are often unstructured and incomplete.
  • Classical data analysis techniques fail to extract valuable process information from these datasets.

Purpose of the Study:

  • To demonstrate the utility of multivariate data analysis (MVDA) for analyzing early development data.
  • To improve understanding of a PER.C6® cell cultivation process using MVDA.

Main Methods:

  • Application of multivariate data analysis (MVDA) as a Process Analytical Technology (PAT) tool.
  • Utilizing Principal Component Analysis (PCA) for dataset exploration and Principal Component Regression (PCR) for model fitting.

Main Results:

  • MVDA provided deeper process understanding than traditional univariate analysis.
  • PCA identified batch deviation causes and process scale sensitivity, previously undetected.
  • Data gaps prevented the use of advanced models like Partial Least Squares (PLS).

Conclusions:

  • MVDA is crucial for extracting relevant information from early development data.
  • Structured experiments with comprehensive analytics enhance the value of early development runs.
  • Implementing MVDA streamlines process development, leading to reduced costs for biopharmaceutical products.